Huadong Medicine Enters $83 Million Deal for GLP-1r Diabetes Treatment

Life Science

China’s I-Mab Inks $548 Million Immunoncology Pact with Genexine

Life Science

CANbridge Files to Start China Trials of Esophageal Cancer Treatment

Life Science

Ambrx Enters $143.5 Million China Deal for Liver Cancer Treatment

Life Science

Zai Lab Pays $44 Million for China Rights to Gastric Cancer Immunotherapy

Life Science

Happy Holidays from NAI Interactive

Energy, Financial Service, Life Science, Mining, Precious Metals, Technology

BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer

Life Science

Novartis Buys Rare Drug Voucher for $130M From Ultragenyx

Life Science

GBIL Pays $29 Million to Acquire Surgical Robot for China from TransEnterix

Life Science

Most Active Canadian Stocks Last Week – Issue 5 week of Dec 11– 15th 2017

Energy, Financial Service, Life Science, Mining, Precious Metals, Technology

Teva Pharmaceutical shares jump after Goldman upgrades embattled drugmaker, predicts turnaround

Life Science

Chi-Med Starts First US Trial of Fruquintinib, an Anti-Angiogenesis Drug

Life Science

Atlas-backed I-O specialist Kyn comes out of stealth mode

Life Science

Life Science & Technology Weekly 125 – Forum highlights investment in life science, high tech

Life Science, Technology

Sinopharm Co-leads $18 Million Round in Nebraska’s Virtual Incision

Life Science